<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Dorsal raphe serotonin neurons inhibit operant responding for reward via inputs to the ventral tegmental area but not the nucleus accumbens: evidence from studies combining optogenetic stimulation and serotonin reuptake inhibition</title>
				<funder ref="#_GB4w9QF">
					<orgName type="full">Canada Research Chair in Developmental Cortical Physiology</orgName>
				</funder>
				<funder ref="#_JR8ANhN">
					<orgName type="full">Canadian Institutes of Health Research</orgName>
					<orgName type="abbreviated">CIHR</orgName>
				</funder>
				<funder ref="#_KHRAwrD">
					<orgName type="full">CIHR postdoctoral fellowship A.R.A.</orgName>
				</funder>
				<funder>
					<orgName type="full">Natural Science and Engineering Research Council of Canada</orgName>
					<orgName type="abbreviated">NSERC</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Springer Science and Business Media LLC</publisher>
				<availability status="unknown"><p>Copyright Springer Science and Business Media LLC</p>
				</availability>
				<date type="published" when="2018-11-12">12 November 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Caleb</forename><forename type="middle">J</forename><surname>Browne</surname></persName>
							<email>caleb.browne@mssm.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<addrLine>100 St. George Street</addrLine>
									<postCode>M5S 3G3</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Section of Biopsychology</orgName>
								<orgName type="institution" key="instit1">Campbell Family Mental Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<addrLine>250 College Street</addrLine>
									<postCode>M5T 1R8</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">R</forename><surname>Abela</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Biopsychology</orgName>
								<orgName type="institution" key="instit1">Campbell Family Mental Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<addrLine>250 College Street</addrLine>
									<postCode>M5T 1R8</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Duong</forename><surname>Chu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhaoxia</forename><surname>Li</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Section of Biopsychology</orgName>
								<orgName type="institution" key="instit1">Campbell Family Mental Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<addrLine>250 College Street</addrLine>
									<postCode>M5T 1R8</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiaodong</forename><surname>Ji</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Evelyn</forename><forename type="middle">K</forename><surname>Lambe</surname></persName>
							<idno type="ORCID">0000-0002-5994-6090</idno>
							<affiliation key="aff2">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Psychology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<addrLine>100 St. George Street</addrLine>
									<postCode>M5S 3G3</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Section of Biopsychology</orgName>
								<orgName type="institution" key="instit1">Campbell Family Mental Health Research Institute</orgName>
								<orgName type="institution" key="instit2">Centre for Addiction and Mental Health</orgName>
								<address>
									<addrLine>250 College Street</addrLine>
									<postCode>M5T 1R8</postCode>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Psychiatry</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Neuroscience</orgName>
								<orgName type="department" key="dep2">Icahn School of Medicine at Mount Sinai</orgName>
								<orgName type="institution">Friedman Brain Institute</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Dorsal raphe serotonin neurons inhibit operant responding for reward via inputs to the ventral tegmental area but not the nucleus accumbens: evidence from studies combining optogenetic stimulation and serotonin reuptake inhibition</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Neuropsychopharmacology</title>
						<title level="j" type="abbrev">Neuropsychopharmacol</title>
						<idno type="ISSN">0893-133X</idno>
						<idno type="eISSN">1740-634X</idno>
						<imprint>
							<publisher>Springer Science and Business Media LLC</publisher>
							<biblScope unit="volume">44</biblScope>
							<biblScope unit="issue">4</biblScope>
							<biblScope unit="page" from="793" to="804"/>
							<date type="published" when="2018-11-12">12 November 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">C542837D74E67E64A54BE70E6B7A7D17</idno>
					<idno type="DOI">10.1038/s41386-018-0271-x</idno>
					<note type="submission">Received: 8 July 2018 Revised: 25 October 2018 Accepted: 2 November 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2025-04-21T20:05+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The monoamine neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) exerts an inhibitory influence over motivation, but the circuits mediating this are unknown.</s><s>Here, we used an optogenetic approach to isolate the contribution of dorsal raphe nucleus (DRN) 5-HT neurons and 5-HT innervation of the mesolimbic dopamine (DA) system to motivated behavior in mice.</s><s>We found that optogenetic stimulation of DRN 5-HT neurons enhanced downstream 5-HT release, but this was not sufficient to inhibit operant responding for saccharin, a measure of motivated behavior.</s><s>However, combining optogenetic stimulation of DRN 5-HT neurons with a low dose of the selective serotonin reuptake inhibitor (SSRI) citalopram synergistically reduced operant responding.</s><s>We then examined whether these effects could be recapitulated if optogenetic stimulation specifically targeted 5-HT terminals in the ventral tegmental area (VTA) or nucleus accumbens (NAc) of the mesolimbic DA system.</s><s>Optogenetic stimulation of 5-HT input to the VTA combined with citalopram treatment produced a synergistic decrease in responding for saccharin, resembling the changes produced by targeting 5-HT neurons in the DRN.</s><s>However, this effect was not observed when optogenetic stimulation targeted 5-HT terminals in the NAc.</s><s>Taken together, these results suggest that DRN 5-HT neurons exert an inhibitory influence over operant responding for reward through a direct interaction with the mesolimbic DA system at the level of the VTA.</s><s>These studies support an oppositional interaction between 5-HT and DA systems in controlling motivation and goal-directed behavior, and have important implications for the development and refinement of treatment strategies for psychiatric disorders such as depression and addiction.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Acquisition of beneficial stimuli such as food, water, or sexual partners depends on the ability of such stimuli to elicit appetitive behaviors-a process known as incentive motivation.</s><s>Incentive motivation is coordinated by interactions among several neurotransmitter systems in the brain, and many lines of evidence suggest that the serotonin (5-hydroxytryptamine; 5-HT) system plays a particularly important role.</s><s>For example, enhancing wholebrain 5-HT activity reduces feeding behavior <ref type="bibr" target="#b0">[1]</ref>, operant responding for food <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>, brain stimulation reward <ref type="bibr" target="#b3">[4]</ref>, drug self-administration <ref type="bibr" target="#b4">[5]</ref>, and appetitive behavior elicited by rewardassociated stimuli <ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>.</s><s>The effects of 5-HT on motivated behavior may be mediated by neurons originating in the brainstem dorsal raphe nucleus (DRN), given that lesions or pharmacological inhibition of these neurons induces feeding <ref type="bibr" target="#b8">[9]</ref>, increases the efficacy of brain stimulation reward <ref type="bibr" target="#b9">[10]</ref>, and supports the formation of a conditioned place preference <ref type="bibr" target="#b10">[11]</ref>.</s><s>Although these inactivation studies suggest that DRN 5-HT neurons have an inhibitory role in motivated behavior, the downstream targets mediating this effect have not been identified.</s></p><p><s>Serotonin may modulate incentive motivation through interactions with the mesolimbic dopamine (DA) system <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref>.</s><s>The mesolimbic DA system is comprised of DA neurons originating in the ventral tegmental area (VTA) which predominantly terminate in the nucleus accumbens (NAc).</s><s>This circuit is critical for reward processing and motivation <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref>; enhancing mesolimbic DA activity reinforces operant behavior <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>, while reducing DA activity inhibits reward-related behaviors <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref>.</s><s>Given that both the VTA and NAc receive extensive serotonergic innervation <ref type="bibr" target="#b22">[23]</ref>, 5-HT neurons are ideally positioned to modulate mesolimbic DA activity at the level of DA cell bodies and their terminals, respectively.</s><s>In fact, serotonin has been shown to reduce DA-dependent behavior <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref>, presumably by suppressing mesolimbic DA system activity <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref>. Thus, 5-HT may inhibit motivated behavior by opposing mesolimbic DA system function via interactions with the VTA and NAc.</s></p><p><s>Here, we use a combined optogenetic and pharmacological approach to identify a potential pathway through which 5-HT may inhibit incentive motivation.</s><s>We first examined whether optogenetic stimulation of 5-HT output from the DRN altered operant responding for the primary reinforcer saccharin as a measure of incentive motivation.</s><s>In contrast to the effects of acute, pharmacological enhancement of whole-brain 5-HT via blockade of 5-HT reuptake <ref type="bibr" target="#b7">[8]</ref>, we found that optogenetic stimulation of DRN 5-HT neurons had no effect on responding for saccharin.</s><s>However, when combined with the selective serotonin reuptake inhibitor (SSRI) citalopram, optogenetic stimulation of DRN 5-HT neurons synergistically reduced responding for saccharin.</s><s>This decrease in responding was recapitulated by targeting 5-HT terminals in the VTA, but not in the NAc.</s><s>These findings suggest that DRN 5-HT neurons inhibit operant responding for reward through an interaction with the VTA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subjects</head><p><s>To express the excitatory opsin channelrhodopsin2 (ChR2) in 5-HT neurons, Ai32 +/+ mice (Jackson 012569; <ref type="bibr" target="#b32">[33]</ref>) were crossed with ePet-Cre +/-mice (Jackson 012712; Fig. <ref type="figure" target="#fig_0">1a</ref>).</s><s>The ePet domain is specific to 5-HT neurons, and has been used to direct expression of ChR2 in 5-HT neurons <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref>.</s><s>Experimental mice were Ai32 +/+ and either ePet-Cre +/-(ChR2+) or ePet-Cre negative (ChR2-).</s><s>ChR2+ mice exhibited expression of ChR2-EYFP in raphe 5-HT neurons (Fig. <ref type="figure" target="#fig_0">1b</ref>), as others have observed <ref type="bibr" target="#b36">[37]</ref>; no EYFPpositive cells were observed in ChR2-mice (data not shown).</s><s>Experiments were performed on adult (10+ weeks old) male mice, unless otherwise specified.</s><s>All mice were group-housed in temperature and humidity controlled environments on a 12 h light/dark cycle (lights on at 7:00 am) with food available ad libitum.</s><s>Following surgery, mice were single-housed.</s><s>In tests of responding for saccharin, mice received 2 h of limited water access each day.</s><s>In all other experiments, water was available ad libitum.</s><s>Experiments adhered to the Canadian Council of Animal Care standards and followed protocols approved by the Centre for Addiction and Mental Health Animal Care Committee and the University of Toronto Faculty of Medicine Animal Care Committee.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drugs</head><p><s>Citalopram HBr (Toronto Research Chemicals, Toronto, Canada) was dissolved in 0.9% saline, and injected intraperitoneally in a volume of 10 ml/kg.</s><s>Citalopram was injected 20 min prior to behavioral testing with dose order determined by a Latin square and all test sessions separated by 72 h.</s><s>Doses are expressed in terms of the free base, and were determined from previous work in our laboratory <ref type="bibr" target="#b7">[8]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ex vivo electrophysiology</head><p><s>Coronal brain slices (400 μm) containing the DRN were obtained for all experiments using a vibratome (Dosaka Pro-7 Linear Slicer; SciMedia) in ice-cold oxygenated sucrose-substituted artificial cerebrospinal fluid (aCSF).</s><s>The slices were recovered at 30 °C for a minimum of 2 h in aCSF solution containing: 128 mM NaCl, 26 mM NaHCO 3 , 10 mM D-glucose, 2 mM CaCl 2 , 2 mM KCl, 2 mM MgSO 4 , 1.25 mM NaH 2 PO 4 , pH 7.4 and saturated with 95% O 2 /5% CO 2 .</s><s>L-Tryptophan (2.5 μM; Sigma-Aldrich) was included during the recovery and recording period to maintain 5-HT synthesis <ref type="bibr" target="#b37">[38]</ref>.</s><s>Patch-clamp recording was performed in L-tryptophan aCSF oxygenated with 95% O 2 /5% CO 2 at 30°C flowing at 3-4 mL/min.</s><s>Patch pipettes (2-5 MΩ) contained solution with: 120 mM potassium gluconate, 5 mM KCl, 10 mM Na 2 -Phosphocreatine, 10 mM HEPES buffer, 2 mM MgCl 2 , 120 mM potassium gluconate, 4 mM K 2 -ATP, 0.4 mM Na 2 -GTP (adjusted to pH 7.3 with KOH).</s><s>DRN neurons were visualized using a fixed-stage microscope (Olympus BX50WI), and 5-HT neurons were targeted based on EYFP expression.</s><s>Whole-cell recordings were performed in current-clamp with a Multiclamp 700B amplifier using pClamp10.2</s><s>software (Molecular Devices).</s><s>Optogenetic stimulation (10 ms pulses; 2-10 Hz) was performed using a microscopemounted collimated LED (473 nm, Thorlabs; 2.5 mW at the slice).</s><s>Citalopram (1 μM) was bath applied in L-tryptophan-containing aCSF to determine effects on membrane properties and optogenetic stimulation response.</s><s>The citalopram concentration was chosen to be within the range of citalopram that reaches the brain following a 1-10 mg/kg systemic injection <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>.</s></p><p><s>In vivo microdialysis and high-performance liquid chromatography Microdialysis procedures were carried out as previously described <ref type="bibr" target="#b40">[41]</ref> and detailed in Supplementary Methods 1.1.</s><s>Throughout the procedure, mice were maintained under inhaled isoflurane anesthesia (2%) with body temperature held at 37 °C.</s><s>Mice were mounted on a stereotaxic frame, and burr holes were made in the skull above the DRN and left NAc.</s><s>An optical fiber (200 µm core, 0.39 NA) connected to a 473 nm laser was positioned above the DRN (Interaural: A/P -0.8, M/L 0, D/V +3.0).</s><s>Laser output was controlled by a waveform generator.</s><s>A microdialysis probe (2 mm cuprophane membrane) was lowered into the NAc (Bregma: A/P + 1.5, M/L -0.7, D/V -5.0 from probe tip).</s><s>The NAc was chosen as a target to sample 5-HT release following optogenetic stimulation because it receives dense input from the DRN, and is a large enough region in the mouse brain to easily accommodate a microdialysis probe.</s><s>The probe was continuously perfused with aCSF at 1 µl/min.</s><s>Sampling began 90 min following probe insertion.</s><s>Samples were collected every 10 min, and immediately analyzed for 5-HT concentration via high-performance liquid chromatography.</s><s>Baseline 5-HT concentration was considered stable when three consecutive samples varied less than 10%.</s><s>Experimental procedures are detailed in Supplementary Methods 1.2.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Behavioral testing</head><p><s>Responding for saccharin was measured in operant conditioning boxes (22 × 18 × 13 cm; Med Associates, St Albans, Vermont).</s><s>On the front wall of the chamber, a reinforcer magazine containing an infrared photodetector centered 2.5 cm above the floor.</s><s>A motor-driven dipper could be raised to deliver 0.02 ml of liquid through a hole in the magazine floor.</s><s>One retractable lever was located on the left of the magazine, which was extended for the duration of operant testing.</s><s>Operant boxes were illuminated by a houselight, and enclosed in a soundattenuating chamber equipped with a ventilation fan.</s><s>Mice could be tethered to optical patch cables through a hole in the roof of the operant box, which was connected in series to an optical commutator and a 473 nm laser controlled by a waveform generator (See Supplementary Methods 2.1).</s></p><p><s>Responding for saccharin was carried out as previously described <ref type="bibr" target="#b7">[8]</ref>, and detailed in Supplementary Methods 2.2.</s><s>Mice were maintained on water restriction throughout testing.</s><s>In 40-min sessions, mice were first trained to lever press for 0.02 ml saccharin (0.2% w/v) presented in a dipper for 5 s on a fixed ratio 1 schedule of reinforcement followed by a random ratio 4 (RR4) schedule of reinforcement (1-in-4 chance of response being rewarded).</s><s>After stabilization of responding on the RR4 schedule, mice underwent stereotaxic surgery (detailed in Supplementary Methods 2.3) to implant optical fibers above the DRN (midline), VTA (bilateral), or NAc (bilateral).</s><s>One week following surgery, responding for saccharin was examined in 20-min sessions with mice tethered to the optical commutator.</s><s>Mice first received 10 re-training sessions, wherein no photostimulation was applied, to learn to accommodate the tether inside the operant chamber.</s><s>In subsequent tests, photostimulation was applied for the duration of testing, unless otherwise specified.</s><s>Experimental procedures are detailed in Supplementary Methods 2.4-2.6.</s></p><p><s>Locomotor activity was assessed as previously described <ref type="bibr" target="#b41">[42]</ref> under dim lighting using 50 × 50 × 35 cm plexiglass chambers with an array of 11 externally mounted photobeams (Med Associates).</s><s>Activity counts were recorded as horizontal photobeam breaks.</s><s>Serotonin syndrome measurements were carried out under bright lighting in a 25 × 35 × 25 cm plexiglass chamber with a side-mounted camera.</s><s>Procedures are described in Supplementary Methods 2.5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histology</head><p><s>Immunohistochemistry was performed on brains collected from ChR2+ and ChR2-mice (see Supplementary Methods 3.1).</s><s>Primary antibodies used were mouse monoclonal anti-TPH2 (1:500; Sigma-Aldrich) and chicken anti-GFP (1:1000; Abcam).</s><s>Secondary antibodies used were donkey anti-mouse Alexa 594 (1:1000; Invitrogen) and donkey anti-chicken Alexa 488 (1:1000; Jackson Immunoresearch).</s><s>Sections were imaged using a confocal microscope.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Data were analyzed using Statistica v13 (TIBCO, Palo Alto, CA).</s><s>Electrophysiology and serotonin syndrome data were analyzed using paired and independent-samples t-tests.</s><s>Neurochemical data were analyzed using one-way ANOVAs with Sample as a within-subjects factor.</s><s>Behavioral testing data with photostimulation alone were analyzed using independent-samples t-tests, or one-way ANOVAs comparing each photostimulation session with previous and subsequent "OFF" sessions.</s><s>Behavioral testing data that combined photostimulation and citalopram treatment were analyzed using mixed-model two or three-way ANOVAs, depending on experimental design, with Group (ChR2-and ChR2+) as a between-subjects factor, and Laser (ON or OFF), Citalopram (vehicle, 5, or 10 mg/kg), and Time (across a session) as withinsubjects factors.</s><s>Post hoc analyses were performed using Fisher's LSD test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Optogenetic stimulation increases DRN 5-HT neuron activity and causes downstream 5-HT release</head><p><s>Ex vivo patch-clamp electrophysiology experiments (Fig. <ref type="figure" target="#fig_0">1c</ref>) confirmed that ChR2-EYFP-expressing 5-HT neurons (n = 13 from four ChR2+ mice) were reliably depolarized by 10 ms pulses of 473 nm blue light, which frequently elicited doublets (Fig. <ref type="figure" target="#fig_0">1d</ref>; Table <ref type="table">S1</ref>).</s><s>These neurons easily followed 30-s stimulation trains at different frequencies (2-10 Hz; Fig. <ref type="figure" target="#fig_0">1e</ref>, top panel).</s><s>Moreover, labeled 5-HT neurons reliably sustained action potential firing in response to prolonged photostimulation trains delivered at 2 Hz (Fig. <ref type="figure" target="#fig_0">1e</ref>, bottom panel; paired-samples t-test: t (7) = 5.52, p &lt; 0.001) and 3 Hz (data not shown).</s><s>In vivo microdialysis experiments in anesthetized female ChR2+ mice (n = 6) confirmed that optogenetic stimulation of DRN 5-HT neurons increased downstream 5-HT release (Fig. <ref type="figure" target="#fig_0">1f</ref>).</s><s>Photostimulation (2.5 Hz, 10 mW, 10 ms pulses) for 20 min enhanced extracellular 5-HT levels (Fig. <ref type="figure" target="#fig_0">1g</ref>; Sample: F (7, 40) = 7.49, p &lt; 0.001; Post hoc: p &lt; 0.001 for samples 2 and 3 vs.</s><s>sample 1).</s><s>Thirty minutes later, photostimulation was reapplied for 60 min.</s><s>During this time, 5-HT levels increased to a plateau within 20 min (Fig. <ref type="figure" target="#fig_0">1g</ref>; Samples 6-12; Sample: F (6,28) = 5.24, p &lt; 0.01; Post hoc: p &lt; 0.01 for samples 7-12 vs. sample 6), consistent with previous reports that 5-HT release can be sustained for extended periods of time <ref type="bibr" target="#b42">[43]</ref>.</s></p><p><s>Optogenetic stimulation of DRN 5-HT neurons does not alter responding for a primary reinforcer We next investigated the effects of optogenetic stimulation (10 mW, 10 ms pulses) of DRN 5-HT neurons on responding for saccharin in ChR2-(n = 10) and ChR2+ (n = 11) mice (Fig. <ref type="figure" target="#fig_0">1h</ref>).</s><s>We tested different photostimulation frequencies (1, 5, 10, and 20 Hz) chosen to represent different firing frequencies of DRN 5-HT neurons observed during reward-related behavior <ref type="bibr" target="#b43">[44,</ref><ref type="bibr" target="#b44">45]</ref>.</s><s>However, optogenetic stimulation had no effect on responding at any frequency tested (Fig. <ref type="figure" target="#fig_0">1i</ref>; Group × Frequency: F (3,57) = 0.06, ns; Group: F (3,57) = 2.94, ns; independent-samples t-tests: all t (19) &lt; 1.57, all p &gt; 0.066).</s><s>It is possible that responding for saccharin was unaffected by optogenetic stimulation because rapid reuptake prevents the accumulation of 5-HT typically required to induce a behavioral change.</s><s>Indeed, most studies examining the involvement of 5-HT in reward-related behavior employ manipulations that impair 5-HT reuptake rather than stimulate 5-HT release, and these two manipulations produce distinct patterns of brain activity <ref type="bibr" target="#b45">[46]</ref>.</s><s>Thus, we next tested whether combining optogenetic stimulation with a low dose of the SSRI citalopram could alter responding for saccharin, which would presumably enable accumulation of 5-HT within downstream targets of the DRN.</s></p><p><s>Combining optogenetic stimulation of DRN 5-HT neurons with citalopram treatment synergistically enhances extracellular 5-HT levels In DRN slices from ChR2+ mice, bath application of 1 µM citalopram resulted in a decrease in firing rate in EYFP-positive neurons (n = 8 from three ChR2+ mice; Fig. <ref type="figure" target="#fig_1">2a</ref>) due to the loss of doublet firing that was observed under baseline conditions.</s><s>This change likely resulted from citalopram's effects on membrane potential (baseline: -68 ± 3 mV, n = 13; citalopram: -81 ± 4 mV, n = 8; unpaired t-test: t (19) = 2.6; p &lt; 0.05) and input resistance (baseline: 521 ± 44 MΩ; citalopram: 340 ± 68 MΩ; t (19) = 2.3; p &lt; 0.05) (Fig. <ref type="figure" target="#fig_1">2b</ref>; Table <ref type="table">S1</ref>).</s><s>Despite these electrophysiological changes, optogenetic stimulation elicited firing of 5-HT neurons at multiple frequencies (Fig. <ref type="figure" target="#fig_1">2c</ref>, top panel).</s><s>Further, with citalopram on board, DRN 5-HT neurons could still be entrained to fire for prolonged periods in response to 2 Hz photostimulation (Fig. <ref type="figure">3c</ref>, bottom panel; paired-samples t-test: t (5) = 4.2, p &lt; 0.01) and 3 Hz photostimulation (data not shown).</s><s>Changes in downstream 5-HT levels following combined DRN photostimulation (2.5 Hz, 10 mW, 10 ms pulses) and citalopram treatment were then measured in ChR2-(n = 4) and ChR2 + (n = 4) mice (Fig. <ref type="figure" target="#fig_1">2d</ref>).</s><s>In ChR2-mice, citalopram increased extracellular 5-HT concentration to a peak within 20 min which steadily declined over testing (Fig. <ref type="figure" target="#fig_1">2e</ref>; Sample: F (12,36) = 3.758, p &lt; 0.01; Post hoc: Samples 3-8 vs. Sample 1, all p &lt; 0.05); DRN photostimulation had no further effect (Post hoc: Samples 4-5 vs. Sample 3, ns).</s><s>In ChR2+ Optogenetic stimulation of DRN 5-HT neurons combined with citalopram treatment synergistically reduces responding for a primary reinforcer Combining DRN photostimulation (2.5 Hz, 10 mW, 10 ms pulses) and citalopram treatment (5, 10 mg/kg, or vehicle) synergistically reduced responding for saccharin in ChR2+ mice relative to ChR2 mice (Fig. <ref type="figure">3a</ref>; mice from Fig. <ref type="figure" target="#fig_0">1i</ref>; Group × Citalopram: F (2,38) = 4.66, p &lt; 0.05; post hoc: 5 and 10 mg/kg both p &lt; 0.05, vehicle, ns).</s><s>A within-session analysis found that this difference was particularly pronounced at the beginning of testing (Fig. <ref type="figure">3b</ref>; Group × Citalopram × Time: F (6,114) = 4.01, p &lt; 0.001).</s><s>Average cumulative response plots (Fig. <ref type="figure">3c</ref>) demonstrate that combined DRN photostimulation and citalopram treatment greatly reduced response rates from the beginning of the session in ChR2+ (bottom panel) mice compared to ChR2-mice (top panel).</s><s>This experiment was repeated using higher photostimulation frequencies, and a similar effect was observed with 5 Hz (Figure <ref type="figure" target="#fig_0">S1-A</ref>; Group × Citalopram × Time: F (6,114) = 11.45,</s><s>p &lt; 0.0001) and 10 Hz (Figure <ref type="figure" target="#fig_0">S1-B</ref>; Group × Citalopram × Time: F (6,114) = 13.79,</s><s>p &lt; 0.0001).</s><s>In tests of locomotor activity, the combination of photostimulation and citalopram increased activity (Fig. <ref type="figure">3d</ref>; Group × Citalopram: F (2,38) = 19.18,</s><s>p &lt; 0.0001), which was consistent across time (Fig. <ref type="figure">3e</ref>; Group × Citalopram × Time: F (6,114) = 0.77, ns; Group × Citalopram: F (2,38) = 19.20,</s><s>p &lt; 0.0001).</s><s>DRN photostimulation combined with citalopram did not produce any observable signs of serotonin syndrome in ChR2+ mice (See Table <ref type="table">S2</ref>; all t (19) &lt; 1.51, all p &gt; 0.148).</s></p><p><s>Optogenetic stimulation of 5-HT input to the VTA combined with citalopram treatment synergistically reduces responding for a primary reinforcer Following acquisition of responding for saccharin on a RR4 schedule of reinforcement, ChR2-(n = 5) and ChR2+ (n = 7) mice received bilateral optical fiber implants targeting the VTA (Fig. <ref type="figure">4a</ref>; Figure <ref type="figure" target="#fig_1">S2A</ref>).</s><s>The effect of photostimulation alone (5 mW, 10 ms pulses) was first examined in ChR2+ mice.</s><s>On alternating test days, mice received either photostimulation at different frequencies (5, 10, or 20 Hz), or no photostimulation ("OFF").</s><s>Photostimulation of 5-HT terminals in the VTA alone had no effect on responding for saccharin in ChR2+ mice (Fig. <ref type="figure">4b</ref>; ANOVAs across all OFF-ON-OFF periods: all F (2,12) &lt; 1.04, all p &gt; 0.325).</s><s>Next, both ChR2-and ChR2+ mice were tested on four occasions in a randomized order following injection of vehicle or 5 mg/kg citalopram with and without the application of 5 Hz VTA photostimulation.</s><s>In ChR2+ mice (Fig. <ref type="figure">4c</ref>, right panels), combining photostimulation of 5-HT terminals in the VTA with citalopram treatment reduced responding in a time-dependent manner (Laser × Citalopram × Time: F (3,18) = 5.09, p &lt; 0.05).</s><s>Tests of simple interactions at each time bin found that within the first 5 min of testing, photostimulation combined with citalopram reduced responding to a greater extent than citalopram alone (Laser × Citalopram interaction: F (1,6) = 32.13,</s><s>p &lt; 0.001; Post hoc: vehicle vs. citalopram at both photostimulation conditions p &lt; 0.01, citalopram 5 mg/kg laser ON vs. OFF p &lt; 0.001).</s><s>Although no significant interactions were observed for the remaining time bins (Laser × Citalopram: all F &lt; 2.80, all p &gt; 0.14), post hoc analyses found a significant reduction in the second time bin only when photostimulation was combined with citalopram (p &lt; 0.05).</s><s>In ChR2-mice (Fig. <ref type="figure">4c</ref>, left panels), no differential effects were observed between citalopram alone and citalopram combined with photostimulation (Laser × Citalopram × Time: F (3,12) = 1.43, ns).</s><s>Average cumulative response plots for ChR2+ mice (Fig. <ref type="figure">4d</ref>) demonstrate that the effect of citalopram combined with photostimulation was driven by a reduction in response rate early on in test sessions.</s><s>In tests of locomotor activity, citalopram alone did not differentially affect ChR2-and ChR2+ mice (Fig. <ref type="figure">4e</ref>; Group × Citalopram: F (1,10) = 3.219, ns; Citalopram: F (1,10) = 0.727, ns).</s><s>When photostimulation was combined with citalopram treatment, activity was increased consistently across time (Fig. <ref type="figure">4f</ref>; Group × Citalopram × Time: F (3,30) = 1.09, ns; Group × Citalopram: F (1,10) = 6.80, p &lt; 0.05).</s></p><p><s>Optogenetic stimulation of 5-HT input to the NAc combined with citalopram treatment does not reduce responding for a primary reinforcer Following acquisition of responding for saccharin, ChR2-(n = 8) and ChR2+ (n = 8) mice received bilateral optical fiber implants targeting the NAc (Fig. <ref type="figure" target="#fig_3">5a</ref>; Figure <ref type="figure" target="#fig_1">S2B</ref>).</s><s>These mice were trained and tested in an identical manner to mice implanted with fibers targeting the VTA (see previous section).</s><s>Photostimulation of 5-HT terminals in the NAc alone had no effect on responding in ChR2+ mice (Fig. <ref type="figure" target="#fig_3">5b</ref>; ANOVAs across all OFF-ON-OFF periods: F (2,14) &lt; 0.25, ns).</s><s>Combining photostimulation of 5-HT terminals in the NAc with citalopram treatment did not differentially affect responding across time for saccharin in ChR2+ mice (Fig. <ref type="figure" target="#fig_3">5c</ref>, right panels; Laser × Citalopram × Time: F (3,21) = 0.68, ns) or ChR2mice (Fig. <ref type="figure" target="#fig_3">5c</ref>, left panels; Laser × Citalopram × Time: F (3,21) = 0.26, ns).</s><s>Average cumulative response plots in ChR2+ mice (Fig. <ref type="figure" target="#fig_3">5d</ref>) show that the combined photostimulation and citalopram condition produced a similar pattern of responding to the citalopram alone condition.</s><s>Similarly, no differential effects on locomotor activity were observed between ChR2-or ChR2+ mice following citalopram alone (Fig. <ref type="figure" target="#fig_3">5e</ref>; Group × Citalopram: F (1,14) = 0.34, ns; Citalopram: F (1,14) = 0.857, ns) or in combination with photostimulation (Fig. <ref type="figure" target="#fig_3">5f</ref>; Group × Citalopram × Time: F (3,42) = 0.93, p = 0.4347; Group × Citalopram: F (1,14) = 0.02, ns).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>The present work examines the role of 5-HT neurons originating in the DRN and their downstream inputs to the mesolimbic DA system in modulating incentive motivation.</s><s>Using a combined optogenetic and pharmacological approach we demonstrate that enhancing DRN 5-HT output suppresses operant responding for the primary reinforcer saccharin, and that these effects are reproduced by selective enhancement of 5-HT input to the VTA, but not the NAc.</s><s>These findings are consistent with an inhibitory role for DRN 5-HT neurons in modulating incentive motivation, and suggest that these effects may be mediated by a direct interaction with the mesolimbic DA system via inputs to the VTA.</s></p><p><s>The majority of ascending 5-HT neurons originate in the DRN <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b46">47]</ref>, and evidence suggests these neurons are important for modulating incentive motivation.</s><s>Dorsal raphe 5-HT neurons appear to code some aspects of rewarding stimuli <ref type="bibr" target="#b43">[44,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref>, and reducing DRN 5-HT output facilitates motivated behaviors <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref>.</s><s>However, previous studies have been unable to identify the effects of enhancing DRN 5-HT output on incentive motivation due to an inability to selectively target 5-HT neurons for activation.</s><s>To overcome this, we used an optogenetic approach to stimulate genetically identified 5-HT neurons.</s><s>Consistent with studies inhibiting DRN 5-HT output, optogenetic stimulation of DRN 5-HT neurons combined with a low dose of the SSRI citalopram reduced operant responding for a primary reinforcer.</s><s>This effect also parallels findings that elevating whole-brain 5-HT reduces operant responding for reward, including work from our lab using similar operant testing procedures <ref type="bibr" target="#b7">[8]</ref>.</s></p><p><s>The ability of DRN 5-HT neurons to inhibit operant responding for reward may be mediated by a downstream interaction with the mesolimbic DA system.</s><s>The DRN innervates both the VTA and the NAc, and 5-HT has been shown to inhibit mesolimbic DA activity.</s></p><p><s>For example, global pharmacological inhibition or lesions of 5-HT neurons increases the firing rate of VTA DA neurons <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b50">51]</ref>, which may be mediated by 5-HT neurons originating in the DRN <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>Given the importance of the mesolimbic DA system in promoting reward-related behavior, inhibition of this system would be expected to reduce operant responding for rewards.</s><s>Indeed, we show that enhancing 5-HT input to the VTA reduces operant responding for saccharin in a manner similar to enhancing DRN 5-HT output.</s><s>These studies provide initial evidence that 5-HT neurons inhibit incentive motivation through a direct interaction with the mesolimbic DA system, consistent with the idea that 5-HT and DA act in opposition to coordinate goal-directed behavior <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b52">53]</ref>.</s></p><p><s>It is possible that photostimulation of 5-HT terminals in the VTA may also activate serotonergic fibers of passage within the medial forebrain bundle located ventral to the optical fiber.</s><s>This may be unlikely considering that stimulation of 5-HT fibers in the NAc itself, a major terminal region of those ascending 5-HT neurons, did not alter responding for saccharin.</s><s>However, this limitation applies to any optogenetic study targeting 5-HT fibers in the midbrain, and should be addressed in future studies.</s></p><p><s>Enhancing 5-HT input to the VTA reduced responding for saccharin, while enhancing 5-HT input to the NAc had no effect.</s><s>Although this finding suggests that the VTA is important for mediating the effects of 5-HT on operant responding for reward, it does not preclude a modulatory role for 5-HT within the NAc.</s><s>Previous studies have demonstrated that activation or blockade of 5-HT receptors in the NAc has various effects on NAc activity and reward-related behavior <ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref>.</s><s>Several factors may explain the lack of effects observed here, including the specific reinforcer used, the behavior examined, or the complexity of 5-HT signaling within the NAc <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>.</s><s>Future studies should investigate how 5-HT signaling within the NAc, as well as the VTA, alters other behavioral measures of incentive motivation, and identify the contribution of different 5-HT receptors to these effects.</s></p><p><s>In order to confirm that photostimulation of the DRN activated 5-HT neurons, we measured extracellular levels of 5-HT in the NAc.</s><s>The NAc was chosen for this purpose because it receives strong input from the DRN <ref type="bibr" target="#b46">[47]</ref>, and is a large enough structure to accommodate placement of a microdialysis probe in the mouse brain.</s><s>Photostimulation of the DRN produced a small and sustained elevation of 5-HT levels, but this manipulation was not sufficient to alter responding for saccharin.</s><s>It is possible that operant responding for a primary reinforcer such as saccharin may be an over-trained response, or may be a behavior that is controlled by multiple neurochemical systems which would be difficult to modify by small, naturally occurring changes in 5-HT release.</s><s>Based on our previous work with citalopram, and serotonin transporter knockout mice, we suggested that 5-HT influences on incentive motivation may be more apparent with reinforcers that maintain lower levels of responding <ref type="bibr" target="#b7">[8]</ref>.</s><s>Accordingly, it would be of interest to examine whether photostimulation of 5-HT neurons, in the absence of citalopram, is sufficient to reduce responding for stimuli such as conditioned, or sensory, reinforcers.</s></p><p><s>Responding for saccharin was reduced by combining a low dose of citalopram with photostimulation of the DRN (and subsequently the VTA).</s><s>This combination also increased levels of extracellular 5-HT in the NAc to a much higher degree than photostimulation alone.</s><s>However, since stimulation of NAc terminals did not alter responding for saccharin, it seems unlikely that the behavioral effects of citalopram combined with DRN stimulation are mediated by this extraordinarily high level of 5-HT release.</s><s>Although we did not measure 5-HT levels in the VTA due to technical limitations of sampling from this region, it is probable that 5-HT levels would also be elevated to a great extent here.</s><s>The magnitude of increase in 5-HT release observed raises a concern about the physiological relevance of these neurochemical effects in relation to behavioral changes.</s><s>However, reductions in responding were apparent within 5 min of testing, much earlier than the peak 5-HT release observed to be produced by this combined manipulation.</s><s>Further, the differential impact of photostimulation (combined with citalopram) of the VTA vs. the NAc points to a functional difference between 5-HT inputs to these two brain areas.</s></p><p><s>The combination of citalopram treatment with optogenetic stimulation of DRN 5-HT neurons or inputs to the VTA reduced operant responding early on in test sessions.</s><s>However, responding still declined further within the session, reaching similar rates of responding as observed under control conditions.</s><s>This suggests that the reduction in responding is not attributable to some generalized non-specific impairment, which might be expected to induce a stable, low level of responding across the session.</s><s>Consistent with this view, the combination of citalopram and optogenetic stimulation did not induce signs of the serotonin syndrome or reduce locomotor activity.</s><s>In fact, a small increase in locomotor activity was observed.</s><s>This effect may relate to the opposing effects of 5-HT 2A and 5-HT 2C receptors on locomotor activity in mice <ref type="bibr" target="#b58">[59]</ref>.</s><s>Given that citalopram has some 5-HT 2C receptor antagonist properties <ref type="bibr" target="#b59">[60]</ref>, this mild increased locomotion may result from a shift towards 5-HT 2A -mediated signaling, facilitating locomotor activity <ref type="bibr" target="#b58">[59]</ref>.</s><s>Thus, it is unlikely that the reductions in responding for reward under these conditions resulted from general disruptions to behavioral sequencing or compromised motor function.</s><s>Examination of the effects of serotonergic manipulations on feeding behavior suggest that 5-HT alters feeding motivation by enhancing the onset of satiety <ref type="bibr" target="#b60">[61]</ref>.</s><s>If a similar process were operating here, we would expect changes in responding to occur late rather than early in the session.</s><s>That pattern was not observed, suggesting that a satiety-like effect does not mediate the reductions in responding.</s><s>One possible explanation for the pattern of behavior observed in these studies is a reduction in incentive motivation for the primary reinforcer.</s><s>We have previously hypothesized that 5-HT inhibits operant responding for multiple types of reinforcers, including saccharin, by reducing incentive motivation <ref type="bibr" target="#b7">[8]</ref>.</s><s>Consistent with this idea, informal observation of the behavior of animals in the present study showed that under conditions of combined citalopram and photostimulation, mice often made a series of responses and collected the reward before disengaging for a brief period and subsequently resuming responding.</s><s>However, further studies using different types of rewarding stimuli are needed to test the hypothesis that the effects observed here are indeed a result of a 5-HT-mediated reduction in incentive motivation.</s></p><p><s>An important observation from these experiments is that behavior was altered only when optogenetic stimulation was combined with citalopram treatment, and the effects were not frequency-dependent.</s><s>These findings may highlight the importance of 5-HT transporter function in regulating 5-HT neurotransmission and its behavioral consequences <ref type="bibr" target="#b42">[43]</ref>.</s><s>The 5-HT transporter tightly regulates 5-HT levels in the extracellular space and rapidly terminates 5-HT signaling <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b61">62]</ref>.</s><s>We show that optogenetic stimulation of DRN 5-HT neurons increases extracellular 5-HT, but this reaches a plateau (Fig. <ref type="figure" target="#fig_0">1g</ref>), likely due to rapid reuptake by the 5-HT transporter.</s><s>When the 5-HT transporter is inhibited by citalopram, extracellular 5-HT is increased (Fig. <ref type="figure" target="#fig_1">2e</ref>) concurrent with a compensatory decrease in the DRN 5-HT neuron firing rate (Figs.</s><s><ref type="figure" target="#fig_1">2b,</ref><ref type="figure">c</ref>), as shown by others as well <ref type="bibr" target="#b62">[63]</ref>.</s><s>Thus, combining optogenetic stimulation with citalopram likely enabled 5-HT to accumulate, which may be required to produce the behavioral effects observed.</s></p><p><s>The present findings may help explain why serotonin-based pharmacotherapies are ineffective in treating psychiatric disorders in certain patients.</s><s>Drugs that block the serotonin transporter, including the SSRIs citalopram (Celexa) and fluoxetine (Prozac), are front-line treatments for depression, obsessive-compulsive disorder, and generalized anxiety disorder.</s><s>However, these compounds typically have a delayed therapeutic onset-a period that can be marked by worsening psychiatric symptoms and elevated risk of suicide <ref type="bibr" target="#b63">[64]</ref>.</s><s>Compared to non-serotonergic antidepressants, SSRIs produce side effects of avolition and sexual dysfunction-possibly reflecting motivational impairments-at higher rates <ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref><ref type="bibr" target="#b67">[68]</ref>.</s><s>Further, antidepressant medications that are less selective for the 5-HT system seem to be more effective in treating motivational symptoms of depression <ref type="bibr" target="#b68">[69,</ref><ref type="bibr" target="#b69">70]</ref>.</s><s>It is plausible that SSRI-mediated enhancement of 5-HT neurotransmission dampens behavioral responses to rewarding stimuli through an interaction with mesolimbic DA system activity, which may lead to exacerbation of pathological symptoms in the short term.</s></p><p><s>In conclusion, the present studies suggest that DRN 5-HT neurons exert an inhibitory influence over incentive motivation for a primary reward, and point towards a DRN-VTA pathway mediating this effect.</s><s>Future studies should more extensively characterize this 5-HT-DA interaction in the context of other behavioral measures of incentive motivation and identify the receptor mechanisms involved.</s><s>A better understanding of how 5-HT and DA interact to control incentive motivation will help uncover fundamental mechanisms of reward processing and motivation, which are critical for refining treatment strategies for psychiatric illness.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig.1Optogenetic stimulation causes dorsal raphe nucleus (DRN) 5-HT neuron activation and enhances downstream 5-HT release, but does not alter operant responding for reward.</s><s>a Expression of ChR2-EYFP specifically in 5-HT neurons was achieved by crossing Ai32 +/+ mice and ePet-cre +/-mice.</s><s>b Representative coronal section showing ChR2-EYFP expression in the DRN: left, 5-HT neurons immunostained for tryptophan hydroxylase-2, a marker of 5-HT neurons; middle, cells expressing ChR2-EYFP; right, merge of tryptophan hydroxylase-2 and ChR2-EYFP channels.</s><s>Scale bar represents 100 μm.</s><s>c Schematic for ex vivo patch-clamp recordings of ChR2-EYFP expressing DRN neurons.</s><s>d Characteristic electrophysiological response of an EYFP-positive serotonergic DRN neuron to current steps and 2 Hz photostimulation trains.</s><s>e Top: average (±SEM) firing frequencies of DRN 5-HT neurons (n = 13) elicited by 30 s trains of optogenetic stimulation (2-10 Hz).</s><s>Bottom: Averaged trace illustrating that extended photostimulation (2 Hz, 200 s) can maintain a significantly elevated firing frequency compared to baseline (paired-samples t-test: t (7) = 5.52, p &lt; 0.001), when tested in a subset of DRN 5-HT neurons.</s><s>f Schematic for in vivo microdialysis with optogenetic stimulation of ChR2-EYFP expressing DRN 5-HT neurons.</s><s>g Average (±SEM) extracellular 5-HT concentration within the NAc from anesthetized ChR2+ mice (n = 5) during periods of photostimulation (blue shaded areas) or no photostimulation (unshaded areas).</s><s>*p &lt; 0.05 vs. previous baseline sample from post hoc analysis.</s><s>h Schematic for optogenetic stimulation (473 nm light, 10 mW, 10 ms pulses) of DRN 5-HT neurons throughout tests of operant responding for saccharin.</s><s>i Optogenetic stimulation of DRN 5-HT neurons does not alter operant responding for saccharin: mean lever presses (±SEM) for saccharin was not different between ChR2-(n = 10; white bars) and ChR2+ mice (n = 11; green bars) at any photostimulation frequency tested (Group × Frequency: F (3,57) = 0.06, ns; Group: F (3,57) = 2.94, ns; independent-samples t-tests: all t (19) &lt; 1.57, all p &gt; 0.066)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Combining optogenetic stimulation of dorsal raphe nucleus (DRN) 5-HT neurons with the SSRI citalopram synergistically enhances downstream levels of extracellular 5-HT.</s><s>a Schematic for ex vivo patch-clamp recordings combining optogenetic stimulation ChR2-EYFP expressing DRN neurons with bath application of 1 μm citalopram.</s><s>b Electrophysiological response of an EYFP-positive 5-HT neuron to current steps in the presence of 1 µM citalopram, and combined with 2 Hz photostimulation.</s><s>c Top: Average (±SEM) firing frequencies of DRN 5-HT neurons (n = 8) elicited by 30 s trains of optogenetic stimulation with 1 μm citalopram in bath (2-10 Hz).</s><s>Bottom: Averaged trace illustrates that extended photostimulation (2 Hz, 200 s) can maintain a significantly elevated firing frequency compared to baseline (paired-samples ttest: t (5) = 4.4, p &lt; 0.01), when tested in a subset of DRN 5-HT neurons.</s><s>d Schematic for in vivo microdialysis experiments combining 2.5 Hz optogenetic stimulation of DRN 5-HT neurons with systemic 5 mg/kg citalopram treatment.</s><s>e Extracellular 5-HT concentration within the NAc of anesthetized ChR2-mice (e; n = 4) and ChR2+ mice (f, n = 4) following intraperitoneal citalopram injection ("CIT") and optogenetic stimulation of DRN 5-HT neurons (blue shaded area).</s><s>Inset in f shows average 5-HT concentration within each phase of sampling for ChR2+ mice.</s><s>*p &lt; 0.05 vs. previous baseline sample</s></p></div></figDesc><graphic coords="5,64.91,59.30,455.98,321.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 Fig. 4</head><label>34</label><figDesc><div><p><s>Fig. 3 Combining optogenetic stimulation (10 mW, 10 ms pulses) of dorsal raphe nucleus (DRN) 5-HT neurons with the SSRI citalopram synergistically reduces operant responding for saccharin.</s><s>a The combination of 2.5 Hz DRN photostimulation and citalopram treatment reduced responding to a greater extent in ChR2+ mice (n = 11, green bars) compared to ChR2-mice (n = 10, white bars; Group × Citalopram: F (2,38) = 4.66, p &lt; 0.05; *p &lt; 0.05 between ChR2-and ChR2+).</s><s>b Within-session data from a; Compared to ChR2-mice (top, white symbols), ChR2+ mice (bottom, green symbols) showed a greater decline in responding early in test sessions (Group × Citalopram × Time: F (6,114) = 4.01, p &lt; 0.001).</s><s>c Average (±SEM, shaded area) cumulative response rate plots for the first 10 min of testing in ChR2-(top, white line) and ChR2+ mice (bottom, green line).</s><s>d Combining DRN 5-HT neuron photostimulation with citalopram treatment increased locomotor activity (Group × Citalopram: F (2,38) = 19.18,</s><s>p &lt; 0.001).</s><s>e Within-session data from d; the increase in activity produced by combined photostimulation and citalopram treatment was consistent across time (Group × Citalopram × Time: F (6,114) = 0.77, ns, Group × Citalopram: F (2,38) = 19.20,</s><s>p &lt; 0.001).</s><s>Data are expressed as mean (±SEM)</s></p></div></figDesc><graphic coords="6,92.35,59.30,419.98,436.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5</head><label>5</label><figDesc><div><p><s>Fig. 5 Combining optogenetic stimulation of 5-HT terminals in the nucleus accumbens (NAc) with 5 mg/kg citalopram treatment does not alter operant responding for saccharin.</s><s>a Schematic for optogenetic stimulation of 5-HT terminals in the NAc (5 mW, 10 ms pulses, 5 Hz) applied throughout tests of responding for saccharin in ChR2-mice (n = 8, white symbols) and ChR2+ mice (n = 8, green symbols).</s><s>DRN, dorsal raphe nucleus; MRN, median raphe nucleus (MRN presented for completeness, weight of lines illustrates differential contribution of 5-HT inputs from DRN and MRN).</s><s>b Photostimulation alone did not alter responding for saccharin in ChR2 + mice at any frequency tested.</s><s>Responding was not different between photostimulation sessions (blue shaded area) and sessions without photostimulation ("OFF"; ANOVAs across all OFF-ON-OFF periods: F (1,15) &lt; 0.25, p &gt; 0.325).</s><s>c Combining photostimulation of 5-HT terminals in the NAc with citalopram treatment did not differentially affect responding for saccharin across time in ChR2-mice (left panels; Laser × Citalopram × Time: F (3,21) = 0.26, ns) and ChR2+ mice (right panels; Laser × Citalopram × Time: F (3,21) = 0.68, ns).</s><s>d Average (±SEM, shaded area) cumulative response rate plots for the first 10 min of test sessions from ChR2+ mice treated with citalopram alone (top) or citalopram combined with photostimulation (bottom).</s><s>Locomotor activity was unaffected by citalopram alone (e; Group × Citalopram: F (1,14) = 0.34, ns; Citalopram: F (1,14) = 0.857, ns) or the combination of citalopram and photostimulation (f; Group × Citalopram × Time: F (3,42) = 0.93, ns; Group × Citalopram: F (1,14) = 0.02, ns).</s><s>Data are expressed as mean (±SEM)</s></p></div></figDesc><graphic coords="9,76.88,59.30,432.00,540.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="3,121.21,59.30,343.45,588.02" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p><s>Neuropsychopharmacology (2019) 44:793 -804 1234567890();,:</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p><s>Neuropsychopharmacology (2019) 44:793 -804</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>ACKNOWLEDGEMENTS C.J.B. and P.J.F.conceptualized the study, designed behavioral and microdialysis experiments, and wrote the manuscript.D.C. and E.K.L. designed the electrophysiological experiments.C.J.B., A.R.A., D.C., X.L. and X.J. carried out experiments.A.R.A., D.C. and E.K.L. edited the manuscript.E.K.L. and P.J.F.supervised experiments.The authors would like to thank <rs type="person">Dr. Junchul Kim</rs> and <rs type="person">Dr. Suzanne Erb</rs> for helpful comments on this work, and <rs type="person">Arthur Godino</rs> and <rs type="person">Dr. Marine Salery</rs> for assistance with figure preparation.</p></div>
			</div>
			<div type="funding">
<div><head>FUNDING AND DISCLOSURE</head><p>This work was supported by an operating grant (<rs type="grantNumber">MOP-13628</rs>) from the <rs type="funder">Canadian Institutes of Health Research (CIHR)</rs> to P.J.F., a <rs type="funder">Canada Research Chair in Developmental Cortical Physiology</rs> to E. K.L., a <rs type="grantName">Discovery Grant</rs> from the <rs type="funder">Natural Science and Engineering Research Council of Canada (NSERC)</rs> to E.K.L., a <rs type="funder">CIHR postdoctoral fellowship A.R.A.</rs>, and a <rs type="grantName">Doctoral Scholarship</rs> to C.J.B.The authors declare no competing interests.</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_JR8ANhN">
					<idno type="grant-number">MOP-13628</idno>
				</org>
				<org type="funding" xml:id="_GB4w9QF">
					<orgName type="grant-name">Discovery Grant</orgName>
				</org>
				<org type="funding" xml:id="_KHRAwrD">
					<orgName type="grant-name">Doctoral Scholarship</orgName>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ADDITIONAL INFORMATION</head><p><s>Supplementary Information accompanies this paper at (https://doi.org/10.1038/</s><s>s41386-018-0271-x).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophaninduced anorexia. Evidence for serotoninergic inhibition of feeding</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Goudie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wheeler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pharm Pharmacol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="318" to="320" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Hussain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhuang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2321" to="2329" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Effects of cocaine and fenfluramine on progressive-ratio performance</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Biochem Behav</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="555" to="558" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Intracranial reward after Lilly 110140 (fluoxetine HCl): evidence for an inhibitory role for serotonin</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Carroll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="189" to="193" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Leccese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Lyness</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="153" to="162" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Effects of fluoxetine and dfenfluramine on cocaine-seeking behavior in rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Burmeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Lungren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Neisewander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="146" to="154" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine</title>
		<imprint>
			<date type="published" when="1995">1995</date>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="155" to="163" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Decreased incentive motivation following knockout or acute blockade of the serotonin transporter: role of the 5-HT2C receptor</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="2566" to="2576" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Hutson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Dourish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Curzon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="347" to="352" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA selfstimulation thresholds in rats</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pazderka-Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clements</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ashcroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="381" to="388" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">H</forename><surname>Ming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Higgins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Opponent interactions between serotonin and dopamine</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Daw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kakade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dayan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neural Netw</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="603" to="616" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">5-HT and mechanisms of defence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Deakin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Graeff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="305" to="315" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Winstanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Deh</forename><surname>Theobald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Dalley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Robbins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="669" to="682" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Salamone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Correa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Brain Res</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="3" to="25" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Predictive reward signal of dopamine neurons</title>
		<author>
			<persName><forename type="first">W</forename><surname>Schultz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurophysiol</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1" to="27" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Brain dopamine and reward</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Rompre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Psychol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="191" to="225" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Chiara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Imperato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="5274" to="5278" />
			<date type="published" when="1988">1988</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Witten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Zalocusky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brodsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="721" to="733" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Fibiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav Biol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="127" to="143" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Koob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Klonoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Fibiger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Biochem Behav</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="781" to="787" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sokolowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Salamone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Biochem Behav</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="557" to="566" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Parent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Descarries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beaudet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="115" to="138" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="188" to="194" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Invernizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cervo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Samanin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="515" to="518" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists</title>
		<author>
			<persName><forename type="first">R</forename><surname>Muscat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Willner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology (Berl)</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="402" to="408" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Dissociable roles for the dorsal and median raphé in the facilitatory effect of 5-HT1A receptor stimulation upon cocaineinduced locomotion and sensitization</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Szumlinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Frys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Kalivas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1675" to="1687" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons</title>
		<author>
			<persName><forename type="first">L</forename><surname>Arborelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chergui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Murase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Nomikos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Höök</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chouvet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Naunyn Schmiede Arch Pharmacol</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="353" to="362" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gervais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rouillard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synapse</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="281" to="291" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hervé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Blanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lemoal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Glowinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Tassin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="422" to="428" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635reversible actions of the highly selective ligands, flesinoxan and S 15535</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lejeune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Millan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synapse</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="172" to="180" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area</title>
		<author>
			<persName><forename type="first">S</forename><surname>Prisco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Esposito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1923" to="1931" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing</title>
		<author>
			<persName><forename type="first">L</forename><surname>Madisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-M</forename><surname>Zhuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berenyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujisawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Neurosci</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="793" to="802" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Dorsal raphe neurons signal reward through 5-HT and glutamate</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1360" to="1374" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Serotonergic versus nonserotonergic dorsal raphe projection neurons: differential participation in reward circuitry</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Mcdevitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tiran-Cappello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Balderas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Britt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ram</forename><surname>Marino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1857" to="1869" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">A genetic approach to access serotonin neurons for in vivo and in vitro studies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Wylie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Lerch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lobur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herlitze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="16472" to="16477" />
			<date type="published" when="2005">2005</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Hippocampal 5-HT input regulates memory formation and Schaffer collateral excitation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">B</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Suri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sargin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="992" to="1004" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases</title>
		<author>
			<persName><forename type="first">R-J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Lambe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Aghajanian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurosci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="945" to="958" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment</title>
		<author>
			<persName><forename type="first">L</forename><surname>Karlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Carlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hiemke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ahlner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1636" to="1644" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Uhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Grauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="179" to="185" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Pharmacological modulation of 5-HT2C receptor activity produces bidirectional changes in locomotor activity, responding for a conditioned reinforcer, and mesolimbic DA release in C57BL/6 mice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Browne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ji</forename><forename type="middle">X</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Harvey-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="2178" to="2187" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tampakeras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sinyard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Slassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Isaac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Higgins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="259" to="267" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Brain dopamine and serotonin differ in regulation and its consequences</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hashemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Dankoski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Takmakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Wightman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="11510" to="11515" />
			<date type="published" when="2012">2012</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hikosaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="5331" to="5343" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Coding of task reward value in the dorsal raphe nucleus</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Bromberg-Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hikosaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="6262" to="6272" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Brainwide mapping of endogenous serotonergic transmission via chemogenetic fMRI</title>
		<author>
			<persName><forename type="first">A</forename><surname>Giorgi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Migliarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Galbusera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maddaloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mereu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Margiani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="910" to="918" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Structure and function of the brain serotonin system</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Jacobs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Azmitia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="165" to="229" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Serotonergic neurons signal reward and punishment on multiple timescales</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Amoroso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Uchida</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Elife</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">463</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Association with reward negatively modulates short latency phasic conditioned responses of dorsal raphe nucleus neurons in freely moving rats</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dalph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Hyland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="5065" to="5078" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Transient firing of dorsal raphe neurons encodes diverse and specific sensory, motor, and reward events</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ranade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">F</forename><surname>Mainen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurophysiol</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="3026" to="3037" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Guiard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mansari</forename><surname>Elm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Merali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Blier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="625" to="639" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The protective action encoding of serotonin transients in the human brain</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lohrenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Saez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Laxton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Witcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1425" to="1435" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Opponency revisited: competition and cooperation between dopamine and serotonin</title>
		<author>
			<persName><forename type="first">Y-L</forename><surname>Boureau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dayan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="74" to="97" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Manipulations of serotonin function in the nucleus accumbens core produce differential effects on ethanol and sucrose seeking and intake</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Czachowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alcohol Clin Exp Res</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1146" to="1155" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="62" to="69" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Potentiation of central reward by localised perfusion of acetylcholine and 5-hydroxytryptamine</title>
		<author>
			<persName><forename type="first">P</forename><surname>Redgrave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Horrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">262</biblScope>
			<biblScope unit="page" from="305" to="307" />
			<date type="published" when="1976">1976</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity</title>
		<author>
			<persName><forename type="first">P</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Molliver</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1952" to="1963" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Van Bockstaele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Pickel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Comp Neurol</title>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="603" to="617" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Halberstadt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Van Der Heijden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ruderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Risbrough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1958" to="1967" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Pälvimäki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Majasuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Laakso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuoppamäki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Syvälahti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="234" to="240" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Is there a role for serotonin (5-hydroxytryptamine) in feeding?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Blundell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Obes</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="15" to="42" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bunin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Wightman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="4854" to="4860" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mannoury La Cour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hanoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Lesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lanfumey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2178" to="2185" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Antidepressants and the risk of suicidal behaviors</title>
		<author>
			<persName><forename type="first">H</forename><surname>Jick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Jick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="338" to="343" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Major depressive disorder, antidepressants, and sexual dysfunction</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Clayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Montejo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="33" to="37" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Opbroek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Laukes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mcgahuey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Katsanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="147" to="151" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="211" to="217" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Serretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiesa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="259" to="266" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">The other face of depression, reduced positive affect: the role of catecholamines in causation and cure</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Demyttenaere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Janka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Aarre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bourin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Canonico</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="461" to="471" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Can recovery from depression be achieved?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Shelton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Tomarken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychiatr Serv</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1469" to="1478" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
